Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-11-15
著者
-
Sasaki Nana
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
谷脇 雅文
高知工科大学工学部
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
SHIMAZAKI Chihiro
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Shimazaki C
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Shimazaki Chihiro
Division Of Hematology And Oncology Department Of Medicine Graduate School Of Medical Science Kyoto
-
Shimazaki Chihiro
京都府立医科大学 循環器内科学･腎臓内科学
-
Iwanaga Masako
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Iwanaga Masako
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
HORIIKE Shigeo
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Kuroda Junya
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Horiike Shigeo
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Horiike Shigeo
Third Department Of Internal Medicine And Department Of Hygiene Kyoto Prefectural University Of Medi
-
Horiike Shigeo
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
UCHIYAMA Hitoji
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
MATSUMOTO Yosuke
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
KIYOTA Miki
Division of Hematology, Kyoto Second Red Cross Hospital
-
MIZUTANI Shinsuke
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
Nakanishi Ryoko
Department Of Molecular-targeting Cancer Prevention Department Of Medicine Graduate School Of Medica
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Kiyota Miki
Division Of Hematology Kyoto Second Red Cross Hospital
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Taniwaki Masafumi
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Uchiyama Hitoji
Department Of Molecular-targeting Cancer Prevention Department Of Medicine Graduate School Of Medica
-
Uchiyama Hitoji
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
YAMAMOTO Mio
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
Yamamoto Mio
Department Of Hematology Matsushita Memorial Hospital
-
Yamamoto Mio
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Mizutani Shinsuke
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Miyazaki Yoshitsugu
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Taniwaki Masafumi
Department Of Clinical Molecular Genetics And Laboratory Medicine Kyoto Prefectural University Of Me
-
Taniwaki Masafumi
The Third Department Of Internal Medicine Kyoto Prefectural Medical School
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
KOBAYASHI Tsutomu
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
TSUTSUMI Yasuhiko
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
OHSHIRO Muneo
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
SHIMURA Yuji
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
NAGOSHI Hisao
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
NAKAYAMA Ryuko
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
Nagoshi Hisao
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Ohshiro Muneo
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Shimura Yuji
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Tsutsumi Yasuhiko
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Kobayashi Tsutomu
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Kuroda Junya
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Tabata Masahiro
The Department Of Internal Medicine Ii Okayama University Medical School
-
Kiyota Miki
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Shimazaki Chihiro
Division Of Hematology And Oncology Department Of Medicine Graduate School Of Medical Science Kyoto Prefectural University Of Medicine
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- イオン注入法によるFe及びCu超微粒子形成とGMR特性(第17回「電磁力関連のダイナミクス」シンポジウム)
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
- Two sporadic cases of infections due to Klebsiella pneumoniae resistant to expanded-spectrum cephalosporins in Japan
- 点欠陥の自己組織化的挙動を利用した微細構造形成法
- イオン照射で導入される点欠陥を利用したナノセル構造の形成
- イオン照射によって導入された点欠陥によるセル構造の形成
- イオン照射による半導体微細セル構造の自己組織化形成
- 低温でのSnイオン注入によってGaSb表面に形成される特異な欠陥構造とその形成機構
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- AuCu合金の相転移と熱膨張挙動
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- A Probable Case of Aspiration Pneumonia Caused by Candida glabrata in a Non-neutropenic Patient with Candidemia
- Clinical Characteristics of Pneumonia Caused by Penicillin Resistant and Sensitive Streptococcus pneumoniae in Japan
- Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans
- Antifungal activity of a new triazole, voriconazole(UK-109496), against clinical isolates of Aspergillus spp
- Case-control study of leukemia and diagnostic radiation exposure
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- 白滝鉱山が地域にもたらしたもの
- 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
- 小特集の企画にあたって
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Genetic Diagnosis of Community-Acquired MRSA: A Multiplex Real-Time PCR Method for Staphylococcal Cassette Chromosome mec Typing and Detecting Toxin Genes
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Clinical Features of Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- IgG4-related disease : Historical overview and pathology of hematological disorders
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.
- Clinical Characteristics of Seven Patients with Aeromonas Septicemia in a Japanese Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Intravascular B-cell lymphoma with hypercalcemia as the initial presentation
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Low ADAMTS-13 activity during hemorrhagic events with disseminated intravascular coagulation